Pharmaceutical News

Javelin Pharmaceuticals CEO Martin J. Driscoll to Present at JP ... - Trading Markets (press release)
Date: Jan 08 2009 | Feed Source: Google

Vaccines and Biotech Create Big Payoffs for Wyeth Pharmaceuticals ... - Manufacturing Business Technology
Date: Jan 08 2009 | Feed Source: Google

Poussot discussed the changing face of the pharmaceutical and biotech industries, as well as new developments involving the company's blockbuster Prevnar ...

Teva says major acquisition unlikely soon - Reuters
Date: Jan 08 2009 | Feed Source: Google

NEW YORK, Jan 8 (Reuters) - Teva Pharmaceutical Industries Ltd (TEVA.O) is unlikely to make a big acquisition in the near future, but might consider a piece ...

Tekmira Announces $11.2 Million 3-Year Manufacturing and ... - MSNBC
Date: Jan 08 2009 | Feed Source: Google

VANCOUVER, BRITISH COLUMBIA - Tekmira Pharmaceuticals Corporation (TSX: TKM) announced today it expects to receive a minimum of $11.2 million over the next ...

Collegium Pharmaceutical Announces FDA Approval of AllerNaze™, a Nasal Inhaled Steroid for the Treatment of Allergic ... (Centre Daily Times)
Date: Jan 08 2009 | Feed Source: Yahoo!

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved AllerNaze™ (triamcinolone acetonide, USP) Nasal Spray, 50 mcg, an aqueous based intranasal steroid indicated for the once daily treatment of nasal symptoms associated with both seasonal allergic rhinitis (SAR) and perennial allergic rhinitis (PAR) in ...

Pharmaceutical trade group adopts voluntary moratorium on gifts to ... - Flesh and Stone
Date: Jan 08 2009 | Feed Source: Google

Responding to a growing chorus of criticism about pharmaceutical company influence over medical practice, the Pharmaceutical Research and Manufacturers of ...

Collegium Pharmaceutical Announces FDA Approval of AllerNaze, a Nasal Inhaled Steroid for the Treatment of Allergic ... (Business Wire via Yahoo! Finance)
Date: Jan 08 2009 | Feed Source: Yahoo!

CUMBERLAND, R.I.----Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration has approved AllerNaze™ Nasal Spray, 50 mcg, an aqueous based intranasal steroid indicated for the once daily treatment of nasal symptoms associated with both seasonal allergic rhinitis and perennial allergic rhinitis in adults and children twelve ...

J&J, Vanderbilt Team Up on Schizophrenia Drugs - Wall Street Journal
Date: Jan 08 2009 | Feed Source: Google

Universities have worked on research projects with pharmaceutical companies for years. A typical setup involves a drug maker funding a university's basic ...

BioMarin Rolls the Dice on a New Lupus Drug - Seeking Alpha
Date: Jan 08 2009 | Feed Source: Google

BioMarin Pharmaceutical (BMRN) and La Jolla Pharmaceutical Company announced that they have entered into an agreement to develop and commercialize Riquent®, ...

Achillion Announces Appointment of New Head of Business Development - MSNBC
Date: Jan 08 2009 | Feed Source: Google

"I've previously worked with Joe and know that he has a deep understanding of the commercial underpinnings of the pharmaceutical market. ...

< 1 2 3 4 > Last ›

PHARMACEUTICAL NEWS

Browse by Category

Browse by Condition